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Abstract
Background: CD4
+ CD25
+ forkhead box P3 (FoxP3)
+ regulatory T cells (T reg cells) are known to suppress adaptive
immune responses, key control tolerance and autoimmunity.
Methods: We challenged the role of CD4
+ T reg cells in suppressing established CD8
+ T effector cell responses by
using the OT-I/II system in vitro and an OT-I-mediated, oligodendrocyte directed ex vivo model (ODC-OVA model).
Results: CD4
+ T reg cells dampened cytotoxicity of an ongoing CD8
+ T effector cell attack in vitro and within
intact central nervous system tissue ex vivo. However, their suppressive effect was limited by the strength of the
antigen signal delivered to the CD8
+ T effector cells and the ratio of regulatory to effector T cells. CD8
+ T effector
cell suppression required T cell receptor-mediated activation together with costimulation of CD4
+ T reg cells, but
following activation, suppression did not require restimulation and was antigen non-specific.
Conclusions: Our results suggest that CD4
+ T reg cells are capable of suppressing CD8
+ T effector cell responses
at the parenchymal site, that is, limiting parenchymal damage in autoimmune central nervous system
inflammation.
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Background
Naturally occurring CD4
+ CD25
+ regulatory T cells (T
reg cells) expressing the transcription factor forkhead
box P3 (FoxP3) are continuously produced in the thy-
mus and are essential for the maintenance of peripheral
immunological self-tolerance and the control of a variety
of physiological and pathological immune responses
[1,2].
Depletion of T reg cells or mutations in the FoxP3
gene lead to spontaneous autoimmune disease in vivo
[3,4]. In vitro coculture experiments demonstrate that
naturally occurring T reg cells potently suppress prolif-
eration and cytokine secretion of naïve CD4
+ and CD8
+
T cells upon stimulation with a specific antigen or with
a polyclonal T cell receptor (TCR) stimulator in the pre-
sence of antigen-presenting cells (APCs) for costimula-
tion in a cell-cell contact-dependent manner [5,6].
Moreover, induction of the FoxP3 gene, which is consid-
ered to control the expression of key molecules mediat-
ing suppression, is capable of converting naïve CD4
+
CD25
- T cells into (inducible) CD4
+ CD25
+ T reg cells
with suppressive function in vivo and in vitro [7,8].
T reg cells can operate at different levels during the
initiation and execution of an immune response. The
suppressive effects of T reg cells on the initiation of an
adaptive (auto)immune response in the peripheral lym-
phoid compartment are well known. However, their pos-
sible impact on an ongoing T cell response at the
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any medium, provided the original work is properly cited.effector site is much less clear [4]. Considering modula-
tion of T reg cells as a potential strategy for therapeutic
intervention in established autoimmune central nervous
system (CNS) disorders, knowledge on the potential of
T reg cells in suppressing T effector cell responses
would be mandatory [1].
In the present work we challenge the role of T reg
cells in suppressing established CD8
+ T effector cell
responses, by using the OT-I/II system of ovalbumin
peptide (OVA) reactive CD8
+ and CD4
+ T cells [9,10]
in coculture experiments in vitro and in brain slice cul-
tures from transgenic mice selectively expressing ovalbu-
min as a cytosolic neo-self antigen in oligodendrocytes
under the control of a truncated myelin basic protein
(MBP) promoter (ODC-OVA mice, [11-14]) ex vivo.
Our results suggest that CD4
+ T reg cells can modulate
antigen-specific CD8
+ T effector cell functions at the
parenchymal level within intact CNS tissue in an antigen
non-specific fashion.
Materials and methods
Mice
Wild-type C57BL/6, ODC-OVA [11], OT-I [10], as well
as OT-II [9] mice were kept under pathogen-free condi-
tions and had access to food and water ad libitum. All
experiments were conducted according to the German
law of animal protection and were approved by local
authorities.
T cell isolation, culture and stimulation
Isolation and stimulation of OT-I, wild-type and OT-II
T reg cells was performed as previously described.
Briefly, spleens were removed and single cell suspen-
sions were generated by mashing spleens through a 40
μm strainer followed by lysis of red blood cells with
ACK buffer. Splenocytes were cultured in Dulbecco’s
modified Eagle medium (DMEM; BioWhittaker, Ver-
viers, Belgium) supplemented with 5% fetal calf serum
(FCS; PAA Laboratories, Pasching, Germany), 10 mM 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES; Gibco, Invitrogen, Darmstadt, Germany), 2
mM L-glutamine (PAA Laboratories), 50 μM 2-mercap-
toethanol (Gibco, Invitrogen), 1% non-essential amino
acids (BioWhittaker) and 25 μg/ml gentamicin (Gibco,
Invitrogen).
OT-I splenocytes were plated at a density of 1 × 10
7
cells/well on a 12-well plate and primed by incubation
for 5 days with OVA257-264 (SIINFEKL; Genescript,
Hamburg, Germany; 1 nM) and interleukin (IL)-2 (200
IU/ml, Pepro Tech, Hamburg, Germany). After 4 days,
IL-2 at a concentration of 200 IU/ml was added again
to the medium. Subsequent to stimulation, H-2 K
b-
restricted OT-I T cells were purified from the spleno-
cyte suspension using the mouse CD8
+ Tc e l li s o l a t i o n
kit (Miltenyi, Bergisch Gladbach, Germany) following
the manufacturer’s instructions and yielding a purity of
> 95%.
H-2 IA
b-restricted CD4
+ CD25
+ T cells were purified
from the OT-II and wild-type splenocyte suspensions
using the mouse CD4 CD25 T cell isolation kit (Milte-
nyi) following the manufacturer’s instructions. Overnight
stimulation of OT-II and wild-type T reg cells was per-
formed with 1 μg/ml anti-CD3 (immobilized) and 1 μg/
ml anti-CD28 (soluble).
T cell activation status was regularly assessed by flow
cytometry using the following antibodies (all by BD
Bioscience, Heidelberg, Germany): rat anti-mouse CD4-
PerCP (no. 553052), rat anti-mouse CD8a-PE (no.
553033), rat anti-mouse CD25-FITC (no. 554071), rat
anti-mouse Alexa Fluor 647-FoxP3 (no. 560401). Flow
cytometry was performed using a FACS-Calibur system
(BD Bioscience) and CellQuest Pro Software (BD
Bioscience).
Cocultivation experiments
In one set of experiments, OT-I splenocytes were stimu-
lated with OVA257-264 for 5 days as described above
with or without wild-type or OT-II T reg cells at differ-
ent concentrations. Proliferating OT-I T cells were iden-
tified by prelabeling with Cell Proliferation Dye eFluor
670 (eBioscience, Frankfurt, Germany). OT-I T cell
maturation markers were assessed by flow cytometry
using rat anti-mouse CD8a-PerCP (no. 553036), rat
anti-mouse CD44-FITC (no. 553133), rat anti-mouse
CD62L-APC (no. 553152) and rat anti-mouse CD11a-PE
(no. 553121) and appropriate isotype controls (all by BD
Bioscience). The relation of OT-I T cells to wild-type or
OT-II T reg cells was assessed by flow cytometry after
cocultivation using rat anti-mouse CD4-PerCP (no.
553052) and rat anti-mouse CD8a-PE (no. 553033).
Cytotoxicity experiments
PKH26 (Sigma-Aldrich, Seelze, Germany) labeled EG.7
[15] and EL-4 cells [16] were used as target cells for sti-
mulated OT-I T cells. Cleaved caspase-3
+ cells were
identified after an incubation period of 6 h as early
apoptotic cells measured by flow cytometry using Alexa
Fluor 488-labeled rabbit anti-mouse cleaved caspase-3
(Cell Signaling, Danvers, MA, USA). OT-II T reg cells
or wild-type T reg cells and OVA257-264 (SIINFEKL)
were added at different concentrations as indicated.
Alternatively, 50 000 EL-4 cells/well were grown on
white 96-well microassay plates (Greiner Bio-One, Frick-
enhausen, Germany) and incubated with different con-
centrations of OVA257-264 for 24 h. Afterwards, EL-4
cells were cocultured with 50.000 activated OT-I T cells
(1:1) or 25.000 OT-II T reg cells (2:1) per well either
alone or in combination for additional 6 h. The amount
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assessed as a parameter of cell viability using the
ATPLite™ Luminescence Assay System (PerkinElmer,
Rodgau-Jügesheim, Germany) according to the manufac-
turer’s instructions. Luminescence was measured on a
Topcount NXT (PerkinElmer). Experiments were per-
formed in triplicate.
Preparation of acute brain slices and coculture
experiments with CD8
+ T cells
Preparation of acute brain slices was performed follow-
ing established procedures as described before [13]
using naïve 6 to 10-week-old transgenic ODC-OVA
mice [11]. Brain slices were incubated alone, with 5 ×
10
5 activated OT-I T cells per slice alone or in combina-
tion with 2.5 × 10
5 wild-type T reg cells or 2.5 × 10
5
OT-II T reg cells per slice, respectively. For upregula-
tion of major histocompatibility complex (MHC)-I
expression levels within the slices, ODC-OVA mice
were treated with lipopolysaccharide (LPS; 0.2 mg/kg
intraperitoneally) 24 h before slice preparation in a sub-
set of experiments. After 6 h, slices were harvested and
embedded in Tissue-Tek OCT compound.
Immunohistochemical staining was performed as pre-
viously described [13]. Primary antibodies against neuro-
nal nuclear antigen (NeuN; 1:1,000, Millipore,
Schwalbach, Germany), NogoA (1:750; Millipore) and
cleaved caspase-3 (1:200, Cell Signaling, Invitrogen)
were used. Secondary antibodies were Alexa Fluor 488-
coupled goat anti-mouse (1:100, BD Bioscience) and
Cy3-coupled goat anti-rabbit (1:300, Dianova, Hamburg,
Germany). Negative controls were obtained by either
omitting the primary or secondary antibody and
revealed no detectable signal (data not shown). For
quantification of cell densities, sections were examined
using an Axiophot2 microscope (Zeiss, Oberkochen,
Germany) equipped with a CCD camera (Visitron Sys-
tems, Tuchheim, Germany). Cell density was determined
within preselected fields within the cortex.
Flow cytometry
For flow cytometry analysis of intracellular effector
molecule content and activation status of OT-I T cells
following incubation in the slice, T cells were retrieved
from slices at the end of the incubation period and
pooled for each experimental condition. Cells were iso-
lated from the interface of 30% to 50% Percoll (Amer-
sham, Freiburg, Germany) centrifuged for 30 minutes at
2.500 rpm. Mononuclear cells were washed and stained
immediately using rat anti-mouse CD8a-PE (BD
Bioscience; no. 553033) and rat anti-mouse CD25-FITC
(BD Bioscience; no. 554071), rat anti-mouse FoxP3
(ebioscience; 17-5773-80). For intracellular granzyme B
staining, cells were pretreated with brefeldin A (BD
Bioscience) for 6 h and stained with CD8a-PE followed
by an intracellular staining using rabbit anti-mouse
granzyme B (ab4059; Abcam, Cambridge, UK) and the
secondary antibody goat anti-rabbit Cy2 (Dianova).
Statistical analysis
All results are presented as mean ± SEM. Statistical ana-
lysis was performed using one-way ANOVA with Bon-
ferroni post hoc tests and Student’s t test modified for
small samples [17], as applicable. P values < 0.05 were
considered significant (indicated as ** in figures).
Results
FoxP3
+ T reg cells suppress antigen-dependent expansion
of naïve CD8
+ T cells in a cell-to-cell ratio-dependent
manner
Following polyclonal TCR stimulation together with
costimulation, T reg cells are known to inhibit expan-
sion of naïve CD4
+ and CD8
+ T cells upon priming
with their cognate antigen [5,6]. To test whether this
holds true for our experimental system, OT-I spleno-
cytes were first antigen stimulated for 5 days with the
MHC class I-restricted OVA257-264 (SIINFEKL) peptide
at different concentrations (1 fM to 1 nM), which
resulted in a concentration-dependent increase of cell
proliferation as revealed by prelabeling with Cell Prolif-
eration Dye eFluor 670 (Figure 1A). Prior to cocultiva-
tion with OT-I splenocytes, CD4
+ CD25
+ T cells were
isolated from wild-type and OT-II splenocyte suspen-
sions and stimulated overnight using 1 μg/ml anti-CD3
(immobilized) and 1 μg/ml anti-CD28 (soluble) yielding
robust FoxP3 expression levels in both cell populations
(Figure 1B). Cocultivation of OT-I splenocytes at an
OVA257-264 peptide concentration of 0.1 pM with wild-
type (data not shown) or OT-II T reg cells (Figure 1C)
at different ratios (2:1 and 1:1) resulted in a concentra-
tion-dependent reduction of cell proliferation. In con-
trast, T cell maturation markers (CD62L, CD44, CD11a)
were not affected by the presence of wild-type (data not
shown) or OT-II T reg cells (Figure 1D). Importantly,
non-activated OT II T reg cells and non-activated wild-
type T reg cells did not exert any suppressive effect
(data not shown). As a control we performed flow cyto-
metry for CD4 and CD8 at the end of the suppression
assay. Upon cocultivation with wild-type or OT-II T reg
cells viable CD4
+ T cells could be detected together
with a strong reduction of CD8
+ T cells, whereas culti-
vation of OT-I T cells alone resulted in robust numbers
of CD8
+ T cells (Figure 1E). This excludes substantial
MHC class I-restricted OVA257-264 peptide presentation
by CD4
+ T reg cells and their subsequent killing by acti-
vated CD8
+ T effector cells.
Hence, following polyclonal TCR stimulation together
with costimulation, both wild-type and OT-II T reg cells
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Page 3 of 9Figure 1 OT-II regulatory T (T reg) cells suppress antigen-dependent expansion of naïve OT-I T cells. (A) OVA257-264 concentration (1 fM-
1 nM) dependence of OT-I splenocyte proliferation assessed after 5 days of stimulation using flow cytometry after prelabeling with Cell
Proliferation Dye eFluor 670. (B) CD4
+ CD25
+ T cells from wild-type and OT-II mice show robust forkhead box P3 (FoxP3) expression following
polyclonal T cell receptor (TCR) stimulation (CD3) together with costimulation (CD28). Representative flow cytometry analysis of FoxP3 expression
levels (dark gray) compared to isotype controls (light gray) in activated CD4
+ CD25
+ T reg cells (left) from wild-type (middle) and OT-II (right)
mice. (C) Representative flow cytometry analysis of the reduction of cell proliferation as revealed by prelabeling with Cell Proliferation Dye eFluor
670 upon stimulation of naïve OT-I splenocytes with OVA257-264 (0.1 pM) for 5 days in the absence or presence of OT-II T reg cells at different
cell-to-cell ratios (2:1 and 1:1). (D) Representative flow cytometry analysis of OT-I T cell maturation markers (CD62L, CD44, CD11a) after 5 days of
stimulation with OVA257-264 (0.1 pM) in the absence or presence of OT-II T reg cells at a cell-to-cell ratio of 2:1. (E) Representative flow cytometry
analysis of CD4
+ and CD8
+ cell populations after 5 days of stimulation of OT-I splenocytes with OVA257-264 (0.1 pM) in the absence (left) or
presence of wild-type (middle) or OT-II (right) T reg cells at a cell-to-cell ratio of 2:1.
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expansion but not maturation of naïve OT-I T cells.
This suppression is independent from their own antigen
(re)stimulation as neither wild-type nor OT-II T reg
cells received additional MHC class II-dependent anti-
gen stimulation during these experiments.
The strength of the antigen stimulation of CD8
+ T
effector cells limits the suppressive effect of FoxP3
+ T reg
cells on cytotoxicity
Activated OT-I T cells induced apoptosis as revealed by
positive immunoreactivity for cleaved caspase-3 in a
cell-to-cell ratio-dependent manner when cocultured for
6 h with EG.7 target cells constitutively presenting
OVA257-264 [15] (Figure 2A). In contrast, EL-4 cells,
which do not present OVA257-264 [16], did not exhibit
caspase-3 activation upon exposure to activated OT-I T
cells at any cell-to-cell ratio (Figure 2A).
To assess a possible suppressive effect of wild-type
and OT-II T reg cells on the cytotoxic activity of acti-
vated OT-I T cells, EG.7 cells were cocultured for 6 h at
a ratio of 1:1 with activated OT-I T cells alone or
together with wild-type or OT-II T reg cells at a ratio of
2:1. Under these conditions wild-type (data not shown)
and OT-II T reg cells (Figure 2B) did not significantly
alter the number of apoptotic EG.7 cells. Constitutive
expression and H-2 K
b-bound presentation of OVA257-
264 by EG.7 cells (approximately 90 K
b:OVA257-264 com-
plexes per cell [18,19]) leads to a strong antigen-depen-
dent perforin-granzyme-mediated killing by activated
Figure 2 Suppression of cytotoxicity by OT-II T reg cells depends on the strength of the antigen stimulation of OT-I T cells in a cell
coculture system. (A) Ratio of apoptotic cleaved caspase-3
+ EG.7 and EL-4 cells after 6 h of cocultivation with activated OT-I T cells at different
ratios in the absence of externally applied OVA257-264 (n = 6, respectively). (B) Representative flow cytometry analysis of cleaved caspase-3 levels
in EG.7 cells cocultured for 6 h at a ratio of 1:1 with activated OT-I T cells in the absence (left panel) and the presence (right panel) of OT-II T reg
cells at a ratio of 2:1 (cleaved caspase-3
+ EG.7 cells: no OT-I T cells: 6.5 ± 1.3%; OT-I T cells: 18.9 ± 2.7%; OT-I T cells + OT-II T reg cells: 18.3 ±
3.4%; P = 0.864; n = 4). (C) OVA257-264 concentration dependence of the OT-II T reg and wild-type T reg cell-mediated reduction of cleaved
caspase-3
+ EL-4 cells induced by activated OT-I T cells (ratio OT-I to T reg: 2:1; ratio OT-I to EL-4: 1:1). At low OVA257-264 concentrations (0.001 to
1 nM) OT-II T reg cells and wild-type T reg cells caused significant reduction of activated OT-I T cell-induced cleaved caspase-3
+ EL-4 cells (n = 6,
respectively). At high OVA257-264 concentrations (10 to 1,000 nM) neither OT-II T reg cells nor wild-type T reg cells exerted any suppressive effect
(n = 6, respectively). (D) OVA257-264 peptide concentration dependence of intracellular ATP levels (detected following cell lysis) as a measure of
cell viability in EL-4 cells following 4 h of cocultivation with activated OT-I T cells (ratio 1:1) in the absence and presence of OT-II T reg cells (ratio
2:1). At low OVA257-264 concentrations (0.001 to 0.1 nM) significantly higher intracellular ATP levels in EL-4 cells (ratio 1:1) were detected in the
presence of OT-II T reg cells as compared to their absence (OVA257-264 0.1 nM: P = 0.0271; n = 8). At high OVA concentrations (1 to 10 nM) OT-II
T reg cells did not exert any suppressive effect (OVA257-264 10 nM: P = 0.734; n = 8). P values < 0.05 were considered significant (indicated as **).
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cells under these conditions.
Therefore, we assessed a possible suppressive effect of
OT-II T reg cells as well as wild-type T reg cells on
OT-I T cell cytotoxicity on EL-4 cells at different
OVA257-264 concentrations but otherwise unchanged
conditions (Figure 2C, D). At low OVA257-264 concentra-
tions (0.001 to 1 nM), which lead to no more than 110
K
b:OVA257-264 complexes per cell [20], activated OT-I T
cells caused significantly lower numbers of cleaved cas-
pase-3 positive EL-4 cells (ratio 1:1) in the presence of
wild-type or OT-II T reg cells (ratio 2:1) as compared to
their absence. In contrast, at high OVA257-264 concentra-
tions (10 to 1,000 nM), which lead to up to 1,120 K
b:
OVA257-264 complexes per EL-4 cell [20], wild-type and
OT-II T reg cells (Figure 2C) did not exert any suppres-
sive effect. This was also true when the amount of ATP
released upon cell lysis was assessed as a measure of
EL-4 cell viability at the end of the incubation period
(Figure 2D). Importantly, non-activated OT II T reg
cells and non-activated wild-type T reg cells did not
exert any suppressive effect (data not shown). This
excludes any unspecific effect resulting from increased
total cell numbers after adding T reg cells in these
experiments. Moreover, in the total absence of OVA257-
264, there was a significantly higher EL-4 cell viability at
the end of the incubation period, that is, no killing and
therefore no suppressive effect of T reg cells (Figure
2D).
These results are consistent with the known high anti-
gen affinity of OT-I T cells, where as few as 1 to 3 K
b:
OVA257-264 complexes per target cell are sufficient to
induce cytotoxicity [14,21,22]. This illustrates the fact
that the suppressive effect of natural CD4
+ T reg cells
depends on the strength of this antigen stimulus deliv-
ered to the CD8
+ T effector cell population. Moreover,
T reg cells exert their suppressive effect independent
from their own antigen (re)stimulation as neither wild-
type nor OT-II T reg cells received additional MHC
class II-dependent antigen stimulation during these
experiments.
FoxP3
+ T reg cells reduce CD8
+ T cell-induced antigen-
specific neural damage in acute brain slices
To assess whether T reg cells exert their suppressive
effect on OT-I T cell-mediated cytotoxicity also in a
more physiological environment, we incubated activated
OT-I T cells in the absence and presence of OT-II T
reg cells or wild-type T reg cells at a ratio of 2:1 for 6 h
in acute brain slices from ODC-OVA mice. These mice
selectively express ovalbumin under the control of a
truncated MBP promoter as a neo-self antigen in ODCs
[11]. Incubation of activated OT-I T cells results in an
ODC-directed CD8
+ T cell attack in ODC-OVA slices,
which leads to perforin-granzyme-dependent death of
ODCs and collateral death of neurons [13]. As these
ODCs exhibit approximately 20 K
b:O V A 257-264 com-
plexes per cell [20], a suppressive effect of T reg cells
on OT-I T cell cytotoxicity seems conceivable according
to our cell culture experiments (given comparable ratios
of OT-I T cells, T reg cells and ODC target cells within
the slice).
In slices from naïve ODC-OVA mice, incubation of
activated OT-I T cells together with wild-type or OT-II
T reg cells at a ratio of 2:1 resulted in a significantly
reduced density of cleaved caspase-3
+ NogoA
+ ODCs as
compared to incubation of OT-I T cells alone (Figure
3A-C, left panels).
During the ODC-directed OT-I T cell attack, neurons
in the gray matter of ODC-OVA slices undergo collat-
eral apoptosis [13]. In the presence of OT-II T reg cells
or wild-type T reg cells, OT-I T cell-mediated collateral
neuronal damage as revealed by the density of cleaved
caspase-3
+ NeuN
+ neurons was also significantly
reduced (Figure 3A-C, right panels). Notably, back-
ground levels of cleaved caspase-3
+ neurons and ODC
are significantly lower than those evoked by OT-I T cell
incubation (Figure 3B) and background levels are known
to be higher in neurons than in ODCs [13] (Figure 3C).
Intraperitoneal treatment of mice with LPS is known
to augment MHC I expression levels and thus antigen-
peptide presentation on neural cell within 24 h [23].
Hence, to assess how T reg cell-mediated suppression of
OT-I T cell cytotoxicity in ODC-OVA slices relates to
MHC I expression, ODC-OVA mice were intraperiton-
ally treated with LPS (0.2 mg/kg) 24 h before brain slice
preparation. Consistent with a LPS-enhanced MHC I
expression, densities of cleaved caspase-3
+ ODCs and
neurons were significantly enhanced upon exposure to
activated OT-I T cells (with similar background levels)
in ODC-OVA slices from LPS-treated as compared to
untreated mice (Figure 3D, left and right panels). Con-
sistent with previous data on the dependence of T reg
cell-mediated suppression on the antigen stimulus deliv-
ered to the CD8
+ T effector cell, we observed no signifi-
cant reduction of cell death of ODCs and collateral
death of neurons by T reg cells under these conditions
(Figure 3D, left and right panels).
At the end of the incubation period, T cells were har-
vested from the slice, pooled and analyzed by flow cyto-
metry. Irrespective of the presence of OT-II T reg cells
or wild-type T reg cells (data not shown), harvested
OT-I T cells displayed similar levels of CD25 expression
as marker of their activation (Figure 4, left panel). How-
ever, staining for the intracellular content of CD8
+ T
cell effector molecules (that is, granzyme B) revealed a
reduced release of effector molecules from OT-I T cells
consistent with the reduced levels of apoptotic ODCs
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Page 6 of 9Figure 3 OT-II regulatory T (T reg) cells reduce OT-I T cell-induced oligodendroglial (and collateral neuronal) apoptosis in acute brain
slices form ODC-OVA mice. (A, B) Representative immunofluorescence images of the cortical gray matter of ODC-OVA slices incubated for 6 h
with (A) or without (B) activated OT-I T cells. Apoptotic NogoA
+ ODCs (left) and neuronal nuclear antigen (NeuN)
+ neurons (right) were detected
by staining for cleaved caspase-3. (C) Densities of cleaved caspase-3
+ NogoA
+ ODCs (left) and NeuN
+ neurons (right) in slices from naïve ODC-
OVA mice under the conditions indicated (n = 6, respectively). P values < 0.05 were considered significant (indicated as **). (D) Densities of
cleaved caspase-3
+ NogoA
+ ODCs (left) and NeuN
+ neurons (right) in slices from ODC-OVA mice treated intraperitoneally with lipopolysaccharide
(LPS) (0.2 mg/kg) 24 h before preparation of brain slices under the conditions indicated (n = 5, respectively). P values < 0.05 were considered
significant (indicated as **).
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of T reg cells (Figure 4, right panel).
Discussion
To what extent T reg cells traffic to and exert their sup-
pressive effects in parenchymal organs under autoim-
mune conditions is currently under debate [1]. It was
recently reported that, following their expansion in the
peripheral lymphoid compartment [24], T reg cells accu-
mulate and further expand in the inflamed CNS of mice
undergoing experimental autoimmune encephalomyelitis
(EAE). However, T reg cells isolated from the CNS of
EAE mice dampened expansion of naïve but not acti-
vated encephalitogenic CD4
+ T cells [25]. Other studies
found accumulation, activation and proliferation of T
reg cells within the CNS during murine EAE, which was
required for the resolution of inflammation and ameli-
oration of the clinical disease [26,27]. Moreover, applica-
tion of myelin-reactive T reg cells could suppress the
initiation and reverse established myelin antigen-induced
EAE in mice [28]. In these studies, up to 50% of CNS
invasive CD4
+ T cells could be T reg cells [27]. How-
ever, in all these experimental systems pathology is
mainly driven by CD4
+ T cells.
Recently, CD8
+ T cells have emerged as key players in
autoimmune neuroinflammation, considered to have
specific relevance for exertion of parenchymal damage
[12]. Hence, we directly tested the capability of CD4
+ T
reg cells to suppress terminal effector function of acti-
vated CD8
+ T cells both in cell culture as well as within
intact CNS tissue [12]. Given a homogenous CD8
+ T
cell receptor repertoire and a fixed ratio of effector-to-
regulatory T cells, CD4
+ T reg cells are capable of limit-
ing cytotoxicity of CD8
+ T cells. The suppressive effect
of CD4
+ T reg cells at the effector site depends on the
strength of the antigen signal of the target cells deliv-
ered to the CD8
+ T effector cells as determined mainly
by the number of antigen peptide-loaded MHC I mole-
cules exposed on the target cell surface [20]. The higher
the OVA257-264 antigen load of EL-4 cell (which express
MHC I molecules in excess; [16,20]) or the higher the
expression of (OVA257-264 antigen loaded) MHC I mole-
cules by ODCs [20] in ODC-OVA slices, the weaker the
relative suppressive effect of OT-II or wild-type T reg
cells on the action of OT-I T effector cells. Notably, to
acquire their suppressive capacity CD4
+ T reg cells
required activation via their T cell receptor together
with a costimulatory signal, but following activation,
suppression did not require restimulation and was anti-
gen non-specific in good agreement with earlier results
[29,30].
In line with previous data obtained from lymph nodes,
CD4
+ T reg cells did not alter activation status but func-
tionally impaired the release of cytotoxic granules result-
ing in higher intracellular levels of effector molecules in
CD8
+ T cells at the effector site [31]. As a note of cau-
tion one should consider that our experimental systems
do not allow an exact estimation to what extent par-
enchymal T reg cell-mediated T effector cell suppres-
sion influences the course and severity of systemic
experimental CNS inflammation. When considering the
therapeutic potential in CNS inflammation, this compo-
nent would certainly be of high relevance (see for exam-
ple, [1]).
Figure 4 OT-II regulatory T (T reg) cells reduce release of cytotoxic effector molecules from OT-I T cells in acute brain slices form
ODC-OVA mice. Representative flow cytometry analysis of activation markers (CD25, left panel) and intracellular effector molecules (granzyme B,
right panel) of OT-I T cells retrieved and pooled from ODC-OVA slices incubated with activated OT-I T cells alone or together with OT-II T reg
cells. Mean fluorescence intensities (MFI) of pooled OT-I T cells from slices incubated in the absence and presence of OT-II T reg cells were 455
vs 478 for CD25 (left panel) and 63 vs 79 for intracellular granzyme B (right panel).
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Taken together our report demonstrates that CD4
+ T
reg cells are able to limit cytotoxicity of an ongoing
CD8
+ T effector cell attack within the intact CNS par-
enchyma. This effect depends on the strength of the
antigen signal delivered to the CD8
+ T effector cells and
(presumably) the ratio of regulatory to effector T cells.
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